• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全面的三级结构集合和软脂酸结合为 RXR 异构体的配体设计提供了分子见解。

Comprehensive Set of Tertiary Complex Structures and Palmitic Acid Binding Provide Molecular Insights into Ligand Design for RXR Isoforms.

机构信息

Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt, Germany.

Structural Genomics Consortium, BMLS, Goethe-University Frankfurt, Max-von-Laue-Str. 15, 60438 Frankfurt, Germany.

出版信息

Int J Mol Sci. 2020 Nov 11;21(22):8457. doi: 10.3390/ijms21228457.

DOI:10.3390/ijms21228457
PMID:33187070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7697888/
Abstract

The retinoid X receptor (RXR) is a ligand-sensing transcription factor acting mainly as a universal heterodimer partner for other nuclear receptors. Despite presenting as a potential therapeutic target for cancer and neurodegeneration, adverse effects typically observed for RXR agonists, likely due to the lack of isoform selectivity, limit chemotherapeutic application of currently available RXR ligands. The three human RXR isoforms exhibit different expression patterns; however, they share high sequence similarity, presenting a major obstacle toward the development of subtype-selective ligands. Here, we report the discovery of the saturated fatty acid, palmitic acid, as an RXR ligand and disclose a uniform set of crystal structures of all three RXR isoforms in an active conformation induced by palmitic acid. A structural comparison revealed subtle differences among the RXR subtypes. We also observed an ability of palmitic acid as well as myristic acid and stearic acid to induce recruitment of steroid receptor co-activator 1 to the RXR ligand-binding domain with low micromolar potencies. With the high, millimolar endogenous concentrations of these highly abundant lipids, our results suggest their potential involvement in RXR signaling.

摘要

视黄醇 X 受体 (RXR) 是一种配体感应转录因子,主要作为其他核受体的通用异二聚体伴侣发挥作用。尽管 RXR 激动剂被认为是癌症和神经退行性疾病的潜在治疗靶点,但通常观察到的不良反应可能是由于缺乏同工型选择性,限制了现有 RXR 配体的化学治疗应用。三种人类 RXR 同工型表现出不同的表达模式;然而,它们具有高度的序列相似性,这是开发亚型选择性配体的主要障碍。在这里,我们报告了饱和脂肪酸棕榈酸作为 RXR 配体的发现,并披露了所有三种 RXR 同工型在棕榈酸诱导的活性构象下的一组统一的晶体结构。结构比较揭示了 RXR 亚型之间的细微差异。我们还观察到棕榈酸以及肉豆蔻酸和硬脂酸具有以低微摩尔效力诱导甾体受体共激活因子 1 募集到 RXR 配体结合域的能力。由于这些高度丰富的脂质具有高、毫摩尔的内源性浓度,我们的结果表明它们可能参与了 RXR 信号转导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80ff/7697888/dc53d7681b7e/ijms-21-08457-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80ff/7697888/c090803c7331/ijms-21-08457-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80ff/7697888/3744b19dcafe/ijms-21-08457-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80ff/7697888/91b44a2c3294/ijms-21-08457-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80ff/7697888/d6508f593e20/ijms-21-08457-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80ff/7697888/dc53d7681b7e/ijms-21-08457-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80ff/7697888/c090803c7331/ijms-21-08457-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80ff/7697888/3744b19dcafe/ijms-21-08457-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80ff/7697888/91b44a2c3294/ijms-21-08457-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80ff/7697888/d6508f593e20/ijms-21-08457-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80ff/7697888/dc53d7681b7e/ijms-21-08457-g005.jpg

相似文献

1
Comprehensive Set of Tertiary Complex Structures and Palmitic Acid Binding Provide Molecular Insights into Ligand Design for RXR Isoforms.全面的三级结构集合和软脂酸结合为 RXR 异构体的配体设计提供了分子见解。
Int J Mol Sci. 2020 Nov 11;21(22):8457. doi: 10.3390/ijms21228457.
2
Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.类固醇受体辅激活因子-1在甲状腺激素受体介导的配体诱导的反式激活中的功能作用分析。
Mol Endocrinol. 1997 Jun;11(6):755-67. doi: 10.1210/mend.11.6.0003.
3
Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies.通过结构和荧光各向异性研究对维甲酸受体/维甲酸X受体(RAR/RXR)异源二聚体与转录共激活因子之间的相互作用进行表征。
J Biol Chem. 2005 Jan 14;280(2):1625-33. doi: 10.1074/jbc.M409302200. Epub 2004 Nov 4.
4
Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors.过氧化物酶体增殖物激活受体和视黄酸受体以不同方式控制类视黄醇X受体异二聚体与配体、共激活因子和共抑制因子的相互作用。
Mol Cell Biol. 1997 Apr;17(4):2166-76. doi: 10.1128/MCB.17.4.2166.
5
A regulatory role for RIP140 in nuclear receptor activation.RIP140在核受体激活中的调控作用。
Mol Endocrinol. 1998 Jun;12(6):864-81. doi: 10.1210/mend.12.6.0123.
6
Ecdysteroid-responsive genes, RXR and E75, in the tropical land crab, Gecarcinus lateralis: differential tissue expression of multiple RXR isoforms generated at three alternative splicing sites in the hinge and ligand-binding domains.热带陆地蟹(Gecarcinus lateralis)中蜕皮甾体反应基因RXR和E75:在铰链区和配体结合域的三个可变剪接位点产生的多种RXR异构体的差异组织表达
Mol Cell Endocrinol. 2005 Oct 20;242(1-2):80-95. doi: 10.1016/j.mce.2005.08.001.
7
Structural insights into the heterodimeric complex of the nuclear receptors FXR and RXR.核受体 FXR 和 RXR 异二聚体复合物的结构见解。
J Biol Chem. 2018 Aug 10;293(32):12535-12541. doi: 10.1074/jbc.RA118.004188. Epub 2018 Jun 22.
8
Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and Pharmacokinetics.奥沙普秦类似物作为选择性 RXR 激动剂,具有优异的性质和药代动力学。
J Med Chem. 2021 Apr 22;64(8):5123-5136. doi: 10.1021/acs.jmedchem.1c00235. Epub 2021 Apr 1.
9
In vivo activation of PPAR target genes by RXR homodimers.视黄酸X受体(RXR)同型二聚体在体内对过氧化物酶体增殖物激活受体(PPAR)靶基因的激活作用。
EMBO J. 2004 May 19;23(10):2083-91. doi: 10.1038/sj.emboj.7600209. Epub 2004 Apr 22.
10
Modulation of RXR function through ligand design.通过配体设计对视黄醇X受体(RXR)功能进行调节。
Biochim Biophys Acta. 2012 Jan;1821(1):57-69. doi: 10.1016/j.bbalip.2011.04.003. Epub 2011 Apr 16.

引用本文的文献

1
Fragment-based discovery of dual ligand pharmacophores for lipid-sensing transcription factors for designed polypharmacology.基于片段的脂质感应转录因子双配体药效团发现用于设计多药理学
RSC Med Chem. 2025 Jul 23. doi: 10.1039/d5md00531k.
2
Structural and mechanistic profiling of Nurr1 modulation by vidofludimus enables structure-guided ligand design.维朵氟米司对Nurr1调节的结构和机制分析有助于进行结构导向的配体设计。
Commun Chem. 2025 May 21;8(1):159. doi: 10.1038/s42004-025-01553-8.
3
Comparative Evaluation and Profiling of Chemical Tools for the Nuclear Hormone Receptor Family 2.

本文引用的文献

1
The orphan nuclear receptor Nurr1 is responsive to non-steroidal anti-inflammatory drugs.孤儿核受体Nurr1对非甾体抗炎药有反应。
Commun Chem. 2020 Jul 3;3(1):85. doi: 10.1038/s42004-020-0331-0.
2
l-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ.左旋甲状腺素和非经典甲状腺激素四碘甲状腺原氨酸是过氧化物酶体增殖物激活受体 γ 的有效激活剂。
J Med Chem. 2020 Jul 9;63(13):6727-6740. doi: 10.1021/acs.jmedchem.9b02150. Epub 2020 Jun 4.
3
Structural basis of binding of homodimers of the nuclear receptor NR4A2 to selective Nur-responsive DNA elements.
核激素受体家族2化学工具的比较评估与分析
ACS Pharmacol Transl Sci. 2025 Mar 14;8(3):854-870. doi: 10.1021/acsptsci.4c00719. Epub 2025 Feb 20.
4
BRF110, an Orally Active Nurr1-RXRα-Selective Rexinoid, Enhances BDNF Expression without Elevating Triglycerides.BRF110,一种口服活性的Nurr1-RXRα选择性类视黄醇X受体激动剂,可增强脑源性神经营养因子(BDNF)的表达而不升高甘油三酯。
J Med Chem. 2025 Feb 27;68(4):4763-4786. doi: 10.1021/acs.jmedchem.4c03046. Epub 2025 Feb 13.
5
PbsNRs: predict the potential binders and scaffolds for nuclear receptors.PbsNRs:预测核受体的潜在结合剂和支架。
Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbae710.
6
Hepatic retinaldehyde deficiency is involved in diabetes deterioration by enhancing PCK1- and G6PC-mediated gluconeogenesis.肝脏视黄醛缺乏通过增强磷酸烯醇式丙酮酸羧激酶1(PCK1)和葡萄糖-6-磷酸酶(G6PC)介导的糖异生作用参与糖尿病病情恶化。
Acta Pharm Sin B. 2023 Sep;13(9):3728-3743. doi: 10.1016/j.apsb.2023.06.014. Epub 2023 Jun 27.
7
Exploring the interactions of antihistamine with retinoic acid receptor beta (RARB) by molecular dynamics simulations and genome-wide meta-analysis.通过分子动力学模拟和全基因组荟萃分析探索抗组胺药与维甲酸受体β(RARB)的相互作用。
J Mol Graph Model. 2023 Nov;124:108539. doi: 10.1016/j.jmgm.2023.108539. Epub 2023 Jun 9.
8
Structural overview and perspectives of the nuclear receptors, a major family as the direct targets for small-molecule drugs.核受体的结构概述和展望,作为小分子药物的直接靶点,这一家族非常重要。
Acta Biochim Biophys Sin (Shanghai). 2022 Jan 25;54(1):12-24. doi: 10.3724/abbs.2021001.
核受体 NR4A2 同源二聚体与选择性 Nur 反应性 DNA 元件结合的结构基础。
J Biol Chem. 2019 Dec 20;294(51):19795-19803. doi: 10.1074/jbc.RA119.010730. Epub 2019 Nov 13.
4
Regulation of RXR-RAR Heterodimers by RXR- and RAR-Specific Ligands and Their Combinations.RXR-RAR 异二聚体受 RXR 和 RAR 特异性配体及其组合的调节。
Cells. 2019 Nov 5;8(11):1392. doi: 10.3390/cells8111392.
5
A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences.一种新型的基于联苯的视黄酸X受体配体化学类型可实现亚型和异二聚体偏好。
ACS Med Chem Lett. 2019 Aug 16;10(9):1346-1352. doi: 10.1021/acsmedchemlett.9b00306. eCollection 2019 Sep 12.
6
Therapeutic modulation of retinoid X receptors - SAR and therapeutic potential of RXR ligands and recent patents.维甲酸 X 受体的治疗调节 - RXR 配体的 SAR 和治疗潜力及最新专利。
Expert Opin Ther Pat. 2019 Aug;29(8):605-621. doi: 10.1080/13543776.2019.1643322. Epub 2019 Jul 22.
7
Computer-Assisted Discovery and Structural Optimization of a Novel Retinoid X Receptor Agonist Chemotype.新型视黄酸X受体激动剂化学类型的计算机辅助发现与结构优化
ACS Med Chem Lett. 2019 Jan 4;10(2):203-208. doi: 10.1021/acsmedchemlett.8b00551. eCollection 2019 Feb 14.
8
Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation.调谐 Wy14,643 对选择性维甲酸 X 受体的调节作用的核受体选择性。
J Med Chem. 2019 Feb 28;62(4):2112-2126. doi: 10.1021/acs.jmedchem.8b01848. Epub 2019 Feb 15.
9
Bexarotent Attenuated Chronic Constriction Injury-Induced Spinal Neuroinflammation and Neuropathic Pain by Targeting Mitogen-Activated Protein Kinase Phosphatase-1.贝沙罗汀通过靶向丝裂原活化蛋白激酶磷酸酶-1 来减轻慢性缩窄性损伤诱导的脊髓神经炎症和神经病理性疼痛。
J Pain. 2020 Nov-Dec;21(11-12):1149-1159. doi: 10.1016/j.jpain.2019.01.007. Epub 2019 Jan 18.
10
OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice.OAB-14,一种倍他罗汀衍生物,通过增加 APP/PS1 小鼠的β-淀粉样蛋白清除率,改善阿尔茨海默病相关的病理和认知障碍。
Biochim Biophys Acta Mol Basis Dis. 2019 Jan;1865(1):161-180. doi: 10.1016/j.bbadis.2018.10.028. Epub 2018 Oct 30.